Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple blood test could spot infections faster after pancreatic surgery

NCT ID NCT07248527

Knowledge-focused Sponsor: Charles University, Czech Republic Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new blood test called ICIS to see if it can detect infections earlier in patients recovering from pancreatic surgery. Researchers will track ICIS levels in 400 adults during their hospital stay, using routine blood samples. The goal is to improve early infection detection, support safer recovery, and reduce complications after surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to a simple blood test that helps doctors spot infections sooner after pancreatic surgery, potentially improving patient recovery.
What could go wrong
This is an observational study, not a treatment trial. The test may not prove accurate enough to change practice, and results may not apply to all patients or hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 400 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2025

Expected to finish

Mar 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients undergoing pancreatic surgery

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients ≥ 18-years-old * Indication for an elective pancreatic procedure * Written informed consent Exclusion Criteria: * Patients \<18 years old. * Known hematologic malignancy or hematological pathology. * Refusal to participate.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Inflamatory markers are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Postoperative Complications Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Inflamatory markers Intensive care (ICU) Pancreatectomy Pancreatic surgery Postoperative care Postoperative complications Postoperative pancreatic fistula Surgical site infection after major surgery

Contacts and locations

Locations

  • Department of Surgery 2nd Faculty of Medicine, Charles University and Military University Hospital Prague

    Prague, Prague 6, 16902, Czechia

More trials for these conditions

Other studies related to the condition(s) this trial covers.